(R)-Didemethyl Citalopram Hydrochloride (CAS 1189694-81-2 (racemic))

(R)-Didemethyl Citalopram Hydrochloride is a chiral compound, representing one of the key metabolites of citalopram, a well-known selective serotonin reuptake inhibitor (SSRI). This compound exhibits its action primarily through the inhibition of the serotonin transporter (SERT), leading to an increase in the synaptic availability of serotonin, a neurotransmitter implicated in mood regulation and neuronal communication. In research applications, (R)-Didemethyl Citalopram Hydrochloride is of significant interest due to its stereospecific activity, offering insights into the pharmacodynamics and pharmacokinetics of enantiomerically pure substances. Its role in elucidating the molecular mechanisms underlying the selective inhibition of serotonin reuptake, as well as its impact on the serotonergic system, makes it useful in neuropharmacological studies. This compound helps in understanding the subtle nuances of drug action at the molecular level, aiding in the development of more targeted and effective research methodologies in the study of neurotransmission and its related disorders.